|
Molecular properties generated using the CDK |
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes (source: FDA (1996)) |
IUPAC Name ![]() |
| 4-amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 6515 | gemcitabine |
Synonyms ![]() |
| gemcitabine hydrochloride |
| Gemzar® |
Database Links ![]() |
|
| CAS Registry No. | 95058-81-4 |
| ChEMBL Ligand | CHEMBL888 |
| DrugBank Ligand | DB00441 |
| PubChem CID | 60750 |
| RCSB PDB Ligand | GEO |
| Search Google for chemical match using the InChIKey | SDUQYLNIPVEERB-QPPQHZFASA-N |
| Search Google for chemicals with the same backbone | SDUQYLNIPVEERB |
| Search PubMed clinical trials | gemcitabine |
| Search PubMed titles | gemcitabine |
| Search PubMed titles/abstracts | gemcitabine |
| Wikipedia | Gemcitabine |
| Comments |
| Gemcitabine is a nucleoside analogue chemotherapeutic. Chemically, the hydrogen atoms on the 2' carbon of deoxycytidine are replaced by fluorine atoms. |